Zimmer Biomet (ZBH) Is Up 7.7% After Q1 Beat And Confident Outlook Commentary - What's Changed
Q1 Surgical Equipment & Consumables - Diversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks
Earnings Preview: What To Expect From Zimmer Biomet’s Report
Zimmer Biomet names new Asia Pacific president
Will Zimmer Biomet’s New Asia Pacific Leader Reframe Its Robotics-Led Growth Story (ZBH)?
Zimmer Biomet Holdings (ZBH) Names Asia Pacific Chief, Is The 8% Discount Enough?
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
BMO Capital Initiates Coverage of Zimmer Biomet Holdings (ZBH) with Market Perform Recommendation
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
BMO Capital Initiates Coverage On Zimmer Biomet Holdings with Market Perform Rating, Announces Price Target of $95
Evercore ISI Group Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $110
Reported Earlier: 'Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India' - Reuters
Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal
Zimmer Biomet to acquire iovera device from Pacira for $140m
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
Zimmer to buy Pacira pain relief device for up to $140M
Zimmer Biomet: Does Slow And Steady Still Win The Race?
Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.